This study tests a personalized cancer vaccine (NECVAX-NEO1) given alongside standard immunotherapy drugs (PD-1/PD-L1 inhibitors) in 20 adults with solid tumors. The goal is to see if the combination is safe and helps control the disease better than immunotherapy alone. Participa…
Phase: PHASE1, PHASE2 • Sponsor: NEC Bio B.V • Aim: Disease control
Last updated May 15, 2026 11:57 UTC